Carsten Berndt

PD Dr. Carsten Berndt is a researcher at the Faculty of Medicine, Heinrich Heine University Düsseldorf, where he leads the Thiology research group. His work focuses on redox biology, particularly the regulation of thiol modifications and their role in disease processes. Dr. Berndt's research has significant implications for understanding neurodegenerative diseases, autoimmune disorders, and cancer.

Dr. Berndt's research interests span multiple areas of redox biology:

• Redox regulation of differentiation and tissue regeneration
• Redox signaling pathways in autoimmune neuroinflammation
• Regulation of iron homeostasis in brain development
• Mechanisms of ferroptosis and cellular defense systems
• Thioredoxin family enzymes (redoxins) and their biological functions

Analysis of Dr. Berndt's recent publications reveals a strong focus on ferroptosis, an iron-dependent form of cell death. His work bridges basic redox biochemistry with clinical applications in neurology and immunology. Key trends include the role of selenium metabolism in preventing ferroptosis, the function of PRDX6 in cellular redox regulation, and connections between redox biology and immune function.

Dr. Berndt has contributed to several significant publications in top-tier journals including Cell, Nature Reviews Biochemistry, and Redox Biology. His collaborative work spans multiple international research groups focused on understanding the fundamental mechanisms of redox regulation in health and disease.

Dr. Berndt's laboratory, the Thiology research group, investigates the molecular mechanisms of thiol modifications and their impact on cellular function. The group employs a range of biochemical, cell biological, and molecular approaches to study redox regulation in neuronal cells and during brain development.